MIFH
LBPH

Migdal Insurance & Financial Holdings’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio LBPH Stock Details LBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,093
Closed -$5K – 725
2021
Q4 		$5K Sell
1,093
-660
-38% -$4.49K ﹤0.01% 650
2021
Q3 		$16K Buy
+1,753
New +$16.2K ﹤0.01% 574

Other funds holding LBPH

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Migdal Insurance & Financial Holdings's LBPH Position: Q1 2022 in Review

Migdal Insurance & Financial Holdings sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q1 2022, closing a stake of 1,093 shares — an estimated $5K sold.

Migdal Insurance & Financial Holdings first reported a position in LBPH in Q3 2021 and held it in 2 quarters. The position peaked at $16K in Q3 2021. 21 funds tracked by Wall St. Rank hold LBPH as of Q1 2022.

  • Migdal Insurance & Financial Holdings reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 1,093 Longboard Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $5K.
  • Migdal Insurance & Financial Holdings first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $16K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2022, filed 2 May 2022.